Anokion
Manufacturing · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Epfl Innovation Park-l 1a, Ecublens, Vau...Phone Number
(857) 320-6607Website
www.anokion.comRevenue
$10.4 MillionIndustry
About Anokion
Anokion Org Chart
Is Anokion your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Anokion launches new products
Congratulate Masked Content for being promoted to Masked Content at Anokion
Funding: Get notified immidiatlly once Anokion has new funding data
Check out if Anokion is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Anokion recently announced quarterly report
Website visits: Recent activity has been detected on your website
Click to see if Anokion had a recent Job posting/layoffs
Anokion, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Anokion has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at Anokion
Find 3 more new buyers
Company Profile Activity
Activity Insights
Anokion is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Anokion is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Anokion.
Anokion financials insights
Gather financial insights about Anokion, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
Series A
$40M
Private Equity
$35M
Anokion Tech Stack
A closer look at the technologies used by Anokion
Most Recent Scoops
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Anokion
Anokion US, Inc. specializes in enhancing the treatment and prognosis of autoimmune diseases through its proprietary antigen-specific immune tolerance technology, surpassing conventional standards of care in effectiveness and specificity. The company applies its innovative approach to diminish the immunogenicity of therapeutic proteins and combat a... Read More